ABUSCREEN RADIOIMMUNOASSAY FOR CANNABINIODS— 510(k) K912757

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K912757 for ABUSCREEN RADIOIMMUNOASSAY FOR CANNABINIODS, Substantially Equivalent on 1991-07-26. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code LDJ
Advisory panel: Clinical Toxicology
Date received: 1991-06-21
Decision date: 1991-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montclair, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.